96 results on '"Kostara C"'
Search Results
2. The Effects of Ezetimibe and/or Orlistat on Triglyceride-Rich Lipoprotein Metabolism in Obese Hypercholesterolemic Patients
3. HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide
4. Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome
5. Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study
6. Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus
7. Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study
8. Diet and exercise effects on aerobic fitness and body composition in seriously mentally ill adults
9. Influence of HDL-cholesterol levels on HDL particles lipid composition in healthy individuals. an NMR-based lipidomic study
10. Serum antioxidant capacity, biochemical profile and body composition of breast cancer survivors in a randomized Mediterranean dietary intervention study.
11. Vitamin D insufficiency in obese patients with severe mental illness taking olanzapine
12. Investigation of the Presence and Progression of Coronary Heart Disease by (1)H-Nmr-Based Lipidomic Profiling of Plasma Lipoproteins
13. INVESTIGATION OF THE PRESENCE AND PROGRESSION OF CORONARY HEART DISEASE by H-1-NMR-BASED LIPIDOMIC PROFILING OF PLASMA LIPOPROTEINS
14. Investigation of the presence of ischemic heart disease by the 1H NMR-based lipidomics of red blood cell membranes
15. AB0342 Serum Transferrin Receptor Ratio to Serum Ferritin and Hepcidin Levels in the Differential Diagnosis of Anemia in Rheumatoid Arthritis Patients
16. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study
17. The Effects of Ezetimibe, Alone or Combined with Orlistat, on Triglyceride-Rich Lipoprotein Metabolism in Overweight and Obese Patients with Hyperlipidaemia
18. Evaluation of established coronary heart disease on the basis of HDL and non-HDL NMR lipid profiling
19. Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemia
20. Apolipoproteins C-Ii and C-Iii and Small Dense Ldl Cholesterol Levels in Non-Diabetic Obese Subjects with Metabolic Syndrome
21. Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study
22. Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
23. Effect of ezetimibe on lipoprotein subfractions in patients with primary dyslipidemias
24. LDL subfractions in patients with metabolic syndrome
25. Rosuvastatin administration decreases apolipoprotein CII and CIII serum levels in patients with primary dysilipidaemia
26. Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemia
27. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study
28. Total plasma lipid analysis in patients with established coronary heart disease by H-1-NMR spectroscopy
29. Plasma lipid analysis by H-1-NMR spectroscopy in patients with established coronary heart disease
30. Lipid composition of HDL and non-HDL lipoprotein fractions in dyslipidemia studied by proton nuclear magnetic resonance spectroscopy
31. Effects of combinations of valsartan with amlodipine or hydrochlorothiazide on renal function and proteinuria in hypertensive patients with metabolic syndrome
32. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine
33. P276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIA
34. MS448 DIFFERENTIAL EFFECT OF SARTANS WITH VARIOUS PPARγ ACTIVATING CAPACITY COMBINED WITH ROSUVASTATIN ON GLUCOSE METABOLISM INDICES
35. Abstract: P933 APOLIPOPROTEINS C-II AND C-III AND SMALL DENSE LDL CHOLESTEROL LEVELS IN NON-DIABETIC OBESE SUBJECTS WITH METABOLIC SYNDROME
36. Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study
37. EFFECTS OF ORLISTAT AND FENOFIBRATE, ALONE OR IN COMBINATION, ON PLASMA APOLIPOPROTEIN C-II AND C-III LEVELS IN METABOLIC SYNDROME PATIENTS
38. PO23-726 EFFECT OF EZETIMIBE ON LIPOPROTEIN SUBFRACTIONS IN PATIENTS WITH PRIMARY DYSLIPIDEMIAS
39. Th-P16:404 Effect of rosuvastatin on apolipoprotein CII and CIII serum levels in patients with primary dyslipidemia
40. We-P11:104 LDL subfractions in patients with metabolic syndrome
41. Effect of rosuvastatin monotherapy or in combination with fenofibrate or [omega]-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome.
42. Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia.
43. Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndrome
44. NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.
45. The effect of rosuvastatin alone or in combination with fenofibrate or omega-3 fatty acids on lipoprotein(a) levels in patients with mixed hyperlipidemia.
46. Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes.
47. Effect of Dapagliflozin on Urine Metabolome in Patients with Type 2 Diabetes.
48. Mediterranean Diet Implementation to Protect against Advanced Lung Cancer Index (ALI) Rise: Study Design and Preliminary Results of a Randomised Controlled Trial.
49. HDL-Mediated Cholesterol Efflux Associates with Incident Kidney Disease.
50. Cardioprotective Properties of HDL: Structural and Functional Considerations.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.